[Discussion Points] NCDs-related Cross-project “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions” (June 17, 2024)
date : 8/19/2024
Tags: Cardiovascular Diseases, Kidney Disease, NCDs, Obesity
The English version of the report has been published. (August 19, 2024)
Health and Global Policy Institute (HGPI) formulated “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions.”
HGPI held the meeting ”The 1st NCDs Meeting in Kyushu” on December 7th 2023 and “The 2nd Meeting on Non-Communicable Diseases (NCDs) in Hokkaido and Tohoku” on March 15th 2024.
This meeting aimed at enhancing the understanding of NCDs, which require intervention and management across sectors in the community and workplaces. The meeting also discussed how NCDs measures should be tailored to local conditions and characteristics, as well as to promote the horizontal development of policies across the community.
HGPI has crystallized the discussion points related to topics that were discussed by participants on these meeting as well as their future prospects.
Discussion point 1: Cardio-renal-metabolic conditions, obesity, and related risk factors can be viewed as interrelated conditions. Rather than advancing regional control measures that target individual conditions, it will be necessary to establish systems using a more integrated approach that spans prevention and treatment to rehabilitation.
Discussion point 2: To improve uptake for routine and specific medical checkups, adopt methods of recommending checkups and providing explanations that reflect the circumstances of the people receiving them.
Discussion point 3: To encourage people whose checkup results require follow-up or more detailed testing to visit health institutions for secondary examinations, it will be important to have conversations that are in line with their lifestyles as well as to eliminate obstacles to medical examinations.
Discussion point 4: To ensure follow-up examinations provided after medical checkups are of high quality, and to enable family doctors to be able to provide referrals to and collaborate with specialists at the right times, it will be necessary to standardize care, to disseminate diagnostic and referral criteria, and to establish networks that facilitate healthcare collaboration.
Discussion point 5: The uneven geographical distribution of specialists results in cases where the windows for early detection are missed, so access to specialists should be improved through healthcare digital transformation (DX).
Discussion point 6: Measures for lifestyle disease control should include measures to reinforce the capacities of prefectural and municipal officials and to promote collaboration among them.
Discussion point 7: In each municipality, public health centers play key roles in cross-cutting collaboration that spans multiple diseases, and their functions should be reinforced.
Discussion point 8: Ensuring smooth collaboration among public health centers, prefectural governments, and municipal governments will be important. Doing so will require establishing systems for collaboration that are centered on public health centers and that involve stakeholders in the region.
Discussion point 9: In addition to measures limited to the public sector, there are examples in which cooperating with the private sector enhanced measures for lifestyle diseases. Cooperation among industry, Government, and academia is important.
Discussion point 10: Expectations are high for a population approach taken through stronger collaboration between community health and occupational health.
Discussion point 11: Obesity control is becoming more important for preventing the exacerbation of other diseases, but obesity measures at the municipal level are generally limited to metabolic syndrome. Obesity awareness must be expanded.
Discussion point 12: A system must be established that allows people to access the right treatment and support that is suited to the policy stage for each disease. Systems for intra-regional collaboration that are designed in a manner that they cut across diseases should also be established.
Discussion point 13: Lifestyle disease control requires collaboration that involves various stakeholders, that encompasses a life course perspective, and that takes aspects related to socioeconomics and welfare into account.
For details, please see the PDF linked below.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
-
2026-07-30
[Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)



